Valirx - Quarterly update on clinical developments
VAL
Wed, 08 Jun 2016, 12:00 BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
George Morris, COO, provides a quarterly Q2 update on clinical progress, where significant improvement has been made on both commercial and scientific fronts.